Responses
Clinical and epidemiological research
Extended report
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study
Compose a Response to This Article
Other responses
No responses have been published for this article.